PubMed Health⌕ Search

PubMed · 15041342

Cyclosporine-induced renal dysfunction.

Abstract

The most practical way to assess and to quantitate the renal function in renal transplant patients is the Cockcroft-Gault equation or an equation used to estimate the glomerular filtration rate (GFR), derived from the Modification of Diet in Renal Disease study. Chronic cyclosporine (CsA) nephrotoxicity causes structural lesions in the kidney and an impairment in the GFR. Determining the composition of the interstitial collagens may be helpful to establish the diagnosis. CsA trough levels are a poor indicator of drug exposure; drug exposure should be quantitated using more accurate methods. Although routine biopsies often show histopathological evidence of structural damage, the excellent kidney graft half-life and the documentation that the creatinine clearance usually remains stable over years in CsA-treated renal transplant patients suggest that its use in kidney transplant patients does not inexorably lead to graft failure. Protocol biopsies show a high incidence of chronic structural CsA toxicity but transplant nephrectomies show that CsA nephrotoxicity as the sole cause of graft loss is extremely rare.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

L C Paul, J H de Fijter. 2004. Cyclosporine-induced renal dysfunction.. https://doi.org/10.1016/j.transproceed.2004.01.005

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Beneficial effect of treatment with cyclosporin A in a case of refractory antisynthetase syndrome.

We report a case of idiopathic inflammatory myopathy accompanied with the presence of anti-Jo1 antibodies and complicated by diffuse parenchymal lung disease (antisynthetase syndrome). Efficacy of different therapeutic agents, including corticosteroids, cyclophosphamide and cyclosporin A, is described. We present beneficial effect of cyclosporin A and corticosteroids regimen, and confirm no benefits of plasmapheresis. An interesting association of the disease onset with toxoplasmosis infection is discussed and difficulties regarding diagnosis of cardiac involvement are addressed. We also review other case reports of this rare disorder of poor prognosis.

Cyclosporine↗

Update on gingival overgrowth by cyclosporine A in renal transplants.

Severe gingival overgrowth is one of the most frequent side effects in renal transplant patients associated with assumption of cyclosporine A. Several associations with age, sex, dosage, duration of therapy or interval since transplantation have been hypothesized. The introduction of alternative immunosuppressant drugs have been suggested to permit better long-term transplant outcomes and a decrease in incidence of gingival overgrowth. The aim of the present paper is to summarize current knowledge regarding aetiology, pathogenesis and management of gingival overgrowth induced by Cyclosporine A.

Cyclosporine↗

Severe psoriasis treated with a new macrolide: everolimus.

Psoriasis is an immune-mediated disease with a chronic relapsing course, and the particularly severe forms that are refractory to traditional therapies are often difficult to manage. Everolimus (Certican; Novartis, Basel, Switzerland) is a new rapamycin-derived macrolide that is used in the prophylaxis of rejection in heart and kidney transplant patients. The mechanism underlying its immunosuppressant and antiproliferative activity is different from, but complementary to, that of calcineurin inhibitors such as ciclosporin. We describe a woman with severe psoriasis treated with everolimus combined with subtherapeutic doses of ciclosporin.

Cyclosporine↗